Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
30%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
PBPH
56
HOLDINGS
28%
ALSO IN CANC
CANC
56
HOLDINGS
25%
ALSO IN PBPH
SECTOR DRIFT (PBPH minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBPH |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 5.7% | 5.3% | 5.3% |
|
ELI LILLY & CO | 15.5% | 4.7% | 4.7% |
 |
NOVARTIS AG | 4.2% | 3.9% | 3.9% |
|
ABBVIE INC | 7.2% | 3.6% | 3.6% |
|
BRISTOL-MYERS SQUIBB CO | 2.7% | 3.1% | 2.7% |
PBPH Overweight Relative to CANC
|
ELI LILLY & CO | 10.8% |
|
JOHNSON & JOHNSON | 7.4% |
|
ABBVIE INC | 3.5% |
|
PFIZER INC | 3.5% |
|
AMGEN INC | 3.0% |
|
GILEAD SCIENCES INC | 2.9% |
|
VERTEX PHARMACEUTICALS INC | 2.8% |
 |
NOVO NORDISK A/S-B | 2.6% |
 |
ASTRAZENECA PLC | 2.5% |
|
GSK PLC | 2.0% |
PBPH Underweight Relative to CANC
|
COGENT BIOSCIENCES INC | -4.8% |
|
REVOLUTION MEDICINES, INC. | -4.7% |
|
GENMAB A/S SPONSORED ADR | -3.7% |
|
BEIGENE LTD. SPONSORED ADR | -3.5% |
|
IOVANCE BIOTHERAPEUTICS INC | -3.4% |
|
HALOZYME THERAPEUTICS INC | -3.2% |
|
EXELIXIS INC | -3.0% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -2.7% |
|
IDEAYA BIOSCIENCES, INC. | -2.6% |
|
IMMUNOME, INC. | -2.6% |